Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Industry News > International Healthcare Media’s Highly Anticipated ADA Compliant Website Is Now Live
  • Industry News

International Healthcare Media’s Highly Anticipated ADA Compliant Website Is Now Live

Rob Oconnell

New accessibility features make IHM’s award-winning content available to all that are vision impaired, vision handicapped, and dyslexia challenged. Innovative Text To Speech AI tool blazes a trail for all publishers

 

Clinton, NJ (February 15, 2022) – As part of its continued mission to connect the global healthcare community with clinically relevant information and education that improves patient care and outcomes, International Healthcare Media (IHM) announced the launch of its highly anticipated ADA-compliant websites for its entire portfolio, including Ophthalmology 360®, Rare Disease 360™, and related microsites. These features enhance an already best-in-class digital media company by making content accessible to all, including the vision impaired and handicapped. What’s more, in characteristic fashion, IHM accessibility criteria extend far beyond ADA compliance standards. Helpful tools include contrast, highlight links, larger text size, text spacing, pause animation, dyslexia-friendly enhancements, line height, text align, and a Text-To-Speech feature.

After the relaunch of IHM’s websites, the additional technological investments come as a continued effort to create a state-of-the-art experience for all users around the world.

 

Chris Ciraulo, President, CEO & Group Publisher said, “International Healthcare Media is thrilled to provide such important features to all of our followers, connections, users, viewers, listeners, and readers. We are fully dedicated to our mission to make our content available to ALL users. This is at the heart of what we strive to accomplish each and every day. As many know, IHM is the force behind our tagline – All Content Should Be This Good® – We are most excited about the Text-To-Speech feature, which allows users to listen to any article. With the click of a button, an artificial intelligence voice reads to the visually impaired and others who may be reading-impaired. We owe our technology team a huge debt of gratitude for providing us with capabilities that enhance our mission of improving the eyesight of patients around the globe.”

Matthew Marano, MD, IHM’s Chief Medical Editor stated, “I am beyond proud to be associated with a pioneering organization that is at the forefront of all it does.” The list of impressive accomplishments, include:

  • Multiple Folio Awards over the last four years
  • A plethora of third-party media partnerships and endorsements
  • An editorial advisory board that includes key opinion leaders and high-level clinical authorities
  • A dominating social media presence
  • Savvy video production capabilities

“And now,” Dr. Marano continued, “added to all this, the new ADA features solidify Ophthalmology 360® and Rare Disease 360™ as stellar digital brands. I have yet to come across a better resource for clinical education tools, patient advocacy and industry news in my 40+ years of practicing medicine. If you are not bookmarking www.ophthalmology360.com and www.rd-360.com or following IHM brands on all its social channels, you are missing out on a quality learning and practice enhancement opportunity.”

 

ABOUT IHM

International Healthcare Media, LLC is a global communications media company that engages healthcare professionals and patients via live congresses, print brands, video, and proprietary digital media assets. IHM helps clinicians deliver quality care, improve patient outcomes and satisfaction, and optimize quality along the continuum of care through brands that target specific clinicians, diseases, and conditions. Using its international reach and access to key thought leaders around the globe, IHM delivers an audience of engaged healthcare professionals by providing them with succinct practical recommendations. Its brands include Ophthalmology 360® | www.ophthalmology360.com, the year-round, multi-content-award-winning platform relied upon by eyecare providers and other specialists; The Ophthalmic Project™, which has scored a multitude of key interviews with leading industry experts and is produced & published by industry rockstar Mark Dlugoss; and Rare Disease 360™ | www.rd-360.com, the healthcare practitioner and patient/caregiver advocate go-to resource for rare disease content, serving an audience of over 500,000 around the globe. For more information, visit ihmholdings.com.

For all media inquiries, contact Juliana Della Pello at [email protected].

Share

Related Content

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

FDA approves Beovu label update to include safety information
  • Cataract

FDA approves first and only extended depth of focus IOL for cataract patients

  • Retina Care 360

Phase 3 SOL-1 trial results are a “landmark achievement” for investigational TKI therapy for wet AMD

  • Industry News

Topcon Healthcare partners with RemoniHealth on remote eye care

1 Min Read
  • Cornea and External Disease

DefEYE Inc launches as independent ophthalmic biologics company

  • Industry News

Harrow to acquire Melt Pharmaceuticals to expand non-opioid sedation options

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon